198 related articles for article (PubMed ID: 37493341)
1. Clonal architecture and evolutionary history of Waldenström's macroglobulinemia at the single-cell level.
García-Sanz R; García-Álvarez M; Medina A; Askari E; González-Calle V; Casanova M; de la Torre-Loizaga I; Escalante-Barrigón F; Bastos-Boente M; Bárez A; Vidaña-Bedera N; Alonso JM; Sarasquete ME; González M; Chillón MC; Alcoceba M; Jiménez C
Dis Model Mech; 2023 Aug; 16(8):. PubMed ID: 37493341
[TBL] [Abstract][Full Text] [Related]
2. MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.
Treon SP; Xu L; Yang G; Zhou Y; Liu X; Cao Y; Sheehy P; Manning RJ; Patterson CJ; Tripsas C; Arcaini L; Pinkus GS; Rodig SJ; Sohani AR; Harris NL; Laramie JM; Skifter DA; Lincoln SE; Hunter ZR
N Engl J Med; 2012 Aug; 367(9):826-33. PubMed ID: 22931316
[TBL] [Abstract][Full Text] [Related]
3. The importance of the genomic landscape in Waldenström's Macroglobulinemia for targeted therapeutical interventions.
Sacco A; Fenotti A; Affò L; Bazzana S; Russo D; Presta M; Malagola M; Anastasia A; Motta M; Patterson CJ; Rossi G; Imberti L; Treon SP; Ghobrial IM; Roccaro AM
Oncotarget; 2017 May; 8(21):35435-35444. PubMed ID: 28423722
[TBL] [Abstract][Full Text] [Related]
4. Waldenström's macroglobulinemia: Two malignant clones in a monoclonal disease? Molecular background and clinical reflection.
Growková K; Kryukova E; Kufová Z; Filipová J; Ševčíková T; Říhová L; Kaščák M; Kryukov F; Hájek R
Eur J Haematol; 2017 Dec; 99(6):469-478. PubMed ID: 28886236
[TBL] [Abstract][Full Text] [Related]
5.
Poulain S; Roumier C; Bertrand E; Renneville A; Caillault-Venet A; Doye E; Geffroy S; Sebda S; Nibourel O; Nudel M; Herbaux C; Renaud L; Tomowiak C; Guidez S; Tricot S; Roche-Lestienne C; Quesnel B; Preudhomme C; Leleu X
Clin Cancer Res; 2017 Oct; 23(20):6325-6335. PubMed ID: 28754818
[No Abstract] [Full Text] [Related]
6. L265P mutation of the MYD88 gene is frequent in Waldenström's macroglobulinemia and its absence in myeloma.
Mori N; Ohwashi M; Yoshinaga K; Mitsuhashi K; Tanaka N; Teramura M; Okada M; Shiseki M; Tanaka J; Motoji T
PLoS One; 2013; 8(11):e80088. PubMed ID: 24224040
[TBL] [Abstract][Full Text] [Related]
7. Waldenström macroglobulinemia whole genome reveals prolonged germinal center activity and late copy number aberrations.
Maclachlan KH; Bagratuni T; Kastritis E; Ziccheddu B; Lu S; Yellapantula V; Famulare C; Argyropoulos K; Derkach A; Papaemmanuil E; Dogan A; Lesokhin A; Usmani SZ; Landgren CO; Palomba LM; Maura F; Dimopoulos MA
Blood Adv; 2023 Mar; 7(6):971-981. PubMed ID: 36332058
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal gammopathy of undetermined significance and Waldenström's macroglobulinemia.
Mailankody S; Landgren O
Best Pract Res Clin Haematol; 2016 Jun; 29(2):187-193. PubMed ID: 27825465
[TBL] [Abstract][Full Text] [Related]
9. Pleural fluid MYD88 L265P mutation supporting diagnosis and decision to treat extramedullary Waldenstrom's macroglobulinemia: a case report.
Barnes M; Sharma P; Kumar V; Kaell A; LiPera W
J Med Case Rep; 2020 Jul; 14(1):98. PubMed ID: 32654665
[TBL] [Abstract][Full Text] [Related]
10. Clone-specific MYD88 L265P and CXCR4 mutation status can provide clinical utility in suspected Waldenström macroglobulinemia/lymphoplasmacytic lymphoma.
Burnworth B; Wang Z; Singleton TP; Bennington A; Fritschle W; Bennington R; Brodersen LE; Wells DA; Loken MR; Zehentner BK
Leuk Res; 2016 Dec; 51():41-48. PubMed ID: 27890075
[TBL] [Abstract][Full Text] [Related]
11. Report of consensus Panel 4 from the 11th International Workshop on Waldenstrom's macroglobulinemia on diagnostic and response criteria.
Treon SP; Tedeschi A; San-Miguel J; Garcia-Sanz R; Anderson KC; Kimby E; Minnema MC; Benevolo G; Qiu L; Yi S; Terpos E; Tam CS; Castillo JJ; Morel P; Dimopoulos M; Owen RG
Semin Hematol; 2023 Mar; 60(2):97-106. PubMed ID: 37173155
[TBL] [Abstract][Full Text] [Related]
12. MYD88 and beyond: novel opportunities for diagnosis, prognosis and treatment in Waldenström's Macroglobulinemia.
Landgren O; Tageja N
Leukemia; 2014 Sep; 28(9):1799-803. PubMed ID: 24573383
[TBL] [Abstract][Full Text] [Related]
13. Report of Consensus Panel 3 from the 11th International workshop on Waldenström's Macroglobulinemia: Recommendations for molecular diagnosis in Waldenström's Macroglobulinemia.
Garcia-Sanz R; Varettoni M; Jiménez C; Ferrero S; Poulain S; San-Miguel JF; Guerrera ML; Drandi D; Bagratuni T; McMaster M; Roccaro AM; Roos-Weil D; Leiba M; Li Y; Qiu L; Hou J; De Larrea CF; Castillo JJ; Dimopoulos M; Owen RG; Treon SP; Hunter ZR
Semin Hematol; 2023 Mar; 60(2):90-96. PubMed ID: 37099028
[TBL] [Abstract][Full Text] [Related]
14. [Waldenström's macroglobulinemia].
Watanabe R
Rinsho Ketsueki; 2015 Oct; 56(10):2074-85. PubMed ID: 26458447
[TBL] [Abstract][Full Text] [Related]
15. Determination of MYD88L265P mutation fraction in IgM monoclonal gammopathies.
Bagratuni T; Markou A; Patseas D; Mavrianou-Koutsoukou N; Aktypi F; Liacos CI; Sklirou AD; Theodorakakou F; Ntanasis-Stathopoulos I; Gavriatopoulou M; Trougakos IP; Lianidou E; Terpos E; Kastritis E; Dimopoulos MA
Blood Adv; 2022 Jan; 6(1):189-199. PubMed ID: 34788399
[TBL] [Abstract][Full Text] [Related]
16. MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenström's macroglobulinemia.
Jiménez C; Sebastián E; Chillón MC; Giraldo P; Mariano Hernández J; Escalante F; González-López TJ; Aguilera C; de Coca AG; Murillo I; Alcoceba M; Balanzategui A; Sarasquete ME; Corral R; Marín LA; Paiva B; Ocio EM; Gutiérrez NC; González M; San Miguel JF; García-Sanz R
Leukemia; 2013 Aug; 27(8):1722-8. PubMed ID: 23446312
[TBL] [Abstract][Full Text] [Related]
17. Single-cell mutation analysis of clonal evolution in myeloid malignancies.
Miles LA; Bowman RL; Merlinsky TR; Csete IS; Ooi AT; Durruthy-Durruthy R; Bowman M; Famulare C; Patel MA; Mendez P; Ainali C; Demaree B; Delley CL; Abate AR; Manivannan M; Sahu S; Goldberg AD; Bolton KL; Zehir A; Rampal R; Carroll MP; Meyer SE; Viny AD; Levine RL
Nature; 2020 Nov; 587(7834):477-482. PubMed ID: 33116311
[TBL] [Abstract][Full Text] [Related]
18. Concurrent Waldenstrom's Macroglobulinemia and Myelodysplastic Syndrome with a Sequent t(10;13)(p13;q22) Translocation.
DeRosa PA; Roche KC; Nava VE; Singh S; Liu ML; Agarwal A
Curr Oncol; 2022 Jun; 29(7):4587-4592. PubMed ID: 35877223
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of Waldenstrom's macroglobulinemia reveals frequent occurrence of two B-cell clones having distinct IgH VDJ sequences.
Kriangkum J; Taylor BJ; Treon SP; Mant MJ; Reiman T; Belch AR; Pilarski LM
Clin Cancer Res; 2007 Apr; 13(7):2005-13. PubMed ID: 17404080
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of refractory cold hemagglutinemia in MYD88 L265P mutation-negative Waldenström's macroglobulinemia with bortezomib.
Izumi M; Tsunemine H; Suzuki Y; Tomita A; Kusumoto T; Kodaka T; Itoh K; Takahashi T
Int J Hematol; 2015 Aug; 102(2):238-43. PubMed ID: 25794560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
